.


:

:



,



( , )

:

































 

 

 

 
FAQ

5

35
* 65 , , : 2 35 . ., 72%. , , ?
* 1-
* 2-
*
*
* 4-

36
*! ., 67 , , , , , . - , , , . .
:
*
* ,
*
*
*

37
, 47 , , . 3 . - : : ( ), . ?
*
*
*
*
*

38
* , 64 , , - , , , , . 25 45 . . . 3- . - 72%, 1 - 67%
:
* ,
* ,
* ,
* ,
* ,

39
* 65- , 20 , 40 , , , . : , , , II , , .
?
* , R V1,2, S V5,6
 * , ST III, AVF, V1, V2;
* , ST I, AVL, V5, V6;
* , ST V2; T- I, AVL, V2.
* , Rv4,5, S III, V1,2

40
* 55- , 20 , , . : , , , II , , .
?
* , ST III, AVF, V1, V2;
* , ST I, AVL, V5, V6;
* , S V5,6, S, S V-
 * , ST V2; T- I, AVL, V2.
* , Rv4,5, SIII, V1,2

41
*! , 65 , , , , . . : II . BP 150/90 .., HR 96 / .
?

*
* 2-
 *
*

42
*! , 52 , , ​​, . : 10 . 30 . : , , . , , rhonhi.
, , ?
* LVC - 85%, FEV1 - 95%
* LVC - 75%, FEV1 - 86%
* - 65%, 1 - 60%
 * LVC - 55%, FEV1 - 75%
* LVC - 45%, FEV1 - 85%

43
* , 45 , , ​​ , . 2 , . , , . , . . 120 / .
?
?
* II
*
*
* VII
*

44
*! , 50 , , , . 1,5 , . , . . . 122 / .
?
* ,
*
*
*
*

45
35 Cefazolinum , , . - , ; - , , .
?
*
*
*
*
*

46
*! 23 , , , , , , , . BP- 70/50 . .
?
*
*
*
*
 *

47
42 , , 400 / . , , Salbutamolum 8 .
?
*
*
*
* Euphyllinum
* i.v.
48
32 2 , , , . , . Flunisolid 400 / .
?
* -
* - 20%
 * -
*
* -

49
* 72- . . - 35,6ºC, , HR - 102 / , BP - 105/90. CBA - - 3,2x1012 / , - 94 / , - 15x109 / , - 2%, - 14%, - 72%, - 10%, - 2%, . , , ?
*
*
*
*
*
50
, 39,8ºC, , 30 RR , BP - 90/55 . . . , - . - . -

?
*
*
*
*
*


1

51
68 , , , , , , . . : . .
?

* +
*
*
*
*

52
*! 52- , , , . . : .
?

*
*
* +
*
*

53
*! 65 , 38 C, . ?

* +
*
*
*
*

54
*! 54 , , , , . : , . : .
?

*
*
*
* +
*

55
*! : - 1020, - , - 30 / , +; : , - , Mycobacterium tuberculosis - .
, , ?

*
* +
*
*
*

56
*! 25 , 2 , , 37,0 C, . : SARS. . . : .
?

*
*
*
*
* +

57
* 29- , , . : SARS. . . , .
?

*
* +
*
*
*

58
*! 48 , 37,8oC, , , . : , . .
?

* +
*
*
*
*

59
! 52 , , . : 10 . 30 : , . : , , .
?

*
*
*
*
* +

60
*! 52 - , . : 10 . 30 . : , . : , , .
?

* +
*
*
*
*

62
*! 62 - , 40 . , . : , . : . .
, , ?
*
* 25
*
*
* +

65
*! 62 - , 40 . , . : , . , , . : .
?

*
*
*
* -
* + ,

66
19 7 . , . : , .
?

* b-2,
*
*
* +
* b-2,

67
*! 2 , 19 , , . . . . . . , - -IgG , . . ?
* +
*
*
*
*

68
*! 8 . ?
*
* -
*
* -
* +

69
*! 42 , . ?
* +
*
*
*
* - , eleuterococcus

70
*! , , . ?
*
* Haemophilus influenzae
* +
*
*

 

1

*! , 57 , , , , . . : , . 120/70 mmHg. 96 . , . . 3.2 × 1012/l; Hb 83 g/l, 1.4, 110 × 109/l, 4.5 , 16 mm/h, , .

?

*

*12-

*

*

*

 

2

*! , 35 . . : , , , , , , , pulse 106 bpm, 90/40 mmHg. . : Er 2.1 × 1012/l, Hb 64 g/l. 0.6, L. 4.4 × 109/l, - 26 mm/h, 6.5 mmol/l.

?

*

*12-deficient anemia

*

*

*

3

*! 14 , , . . , , 3 . : . H 80 g/l, erythrocytes 2 × 1012/l, 0.8, reticulocytes 25%. 34 mol/l.

?

*

*12-deficient anemia

*Folic-deficient anemia

*Aplasticanemia

*Microspherocytosis

 

4

*! 40 , , , , . . : , . . : Hb 66 g/l, Er. 2,1× 1012/l, 1.0, L 1,5 × 109/l, e.0%, p. 11%, s.36%, l 50%, m 10%, reticulocytes 0.2%, thrombocytes 55 × 109/l, 51 mm/h. , : .

?

*immunethrombocytopenia

*acute hemolytic anemia

*immune pancytopenia

*aplastic anemia

*posthemorrhageanemia

 

5..

*!, 22 , . 2 .: . , 3 . : H. 83 g/l, Er. 2.3 × 1012/l, reticulocytes 20%, 210 × 109/l, leuk. 4.5 × 109/l. , ,macropolycytes. 110 mol/l.

?

*

*Immune pancytopenia

*Aplastic anemia

*Glucoso-6-FDG-deficient anemia

*Minkowsky-Shauffarddisease

 

6

*! 33 38.7, , , , . , . , . , ,

Which diagnosis is MOST probable?

*

*Acute myeloblastic leucosis

*Chronic lymphocytic leukemia

*Chronic myelogenous leukemia

*Hodgkin'sdisease

 

7

*! 19 38.7, , , . , . ,

?

*

*Anemia detection

*Thrombocytopenias detection

*Leukocytosis detection

*Megaloblasts detection

 

8

*! 64 ,. . . . , ( ) . . . ,

ER 3x1012/l, 90 g/l, Leukocytes 90x109/l., myeloblasts 4%, promyelocytes 6%, metamyelocytes 10%, 10%.

:

*Acute lymphoblastic leucosis

*Acute myeloblastic leucosis

*Chronic lymphocytic leukemia

*

*Hodgkin's disease

 

9

*! 28 , , . . : 4,0, 4,5, , 15. ?
WhichdiagnosisisMOSTprobable?

*- (DICsyndrome)

* (Acuteleucosis)

* (Hemolyticanemia)

* (Aplasticanemia)

* (Autoimmunethrombocytopenia)

 

10

*!, 35 , 5 , . , . , . , . . : 94 /, 3,8, 0,64, 6,2, 3%, 67%, 2%, 23%, 5%, 15,0. ?

* (Antiobiotics)

* (Prednisolonum)

* (Thrombopoietin)
* (Wholebloodtransfusion)

* (Fresh frozen plasma transfusion)

11

*! 45 , , , , ( ). . : , , . , 22 . , , . 100 , , . 90/60 .. : 2,9, 87, 0,8, 4,4, 22 /, 5,3 /. ?

 

* (iron sulphate orally)

* (prednisolone orally)

*/ (iron sulphate intravenously)

*/ (deferoxamin intramuscularly)

*/ (concentrated red cells intravenously)

 

12

*!, 46 , , , . : . : , . , 22 . , , . 100/60 .. 96 . . . . : 2,5, 94 /, 1,3, 3,4, 182, 23 /. : 7%. . ?

* (Bonemarrowpuncture 1 monthlater)

* 3 (Bonemarrowpuncture 3 monthlater)

* 10-12 (Common blood analyses on 10-12 day of treatment)

* 20-21 (Common blood analyses on 20-21 day of treatment)

* 29-30 (Common blood analyses on 29-30 day of treatment)

 

 

13
*! , 55 , , , , . . : - , . . : Hb 45 / , . 1,9 × 1012 / , 1,0, 1,5 × 109 / , 0%, . 11%, .36%, 50%, 10%, 0,2%, 55 × 109 / , ESR - 51 / . , : . - HCV - . ?

*

+*

*

* GM-CGF

* - IL-1

14

! 55 , , , . 10 - . : : Er. 2,8 × 1012 / , Hb 76 / , 1,4, L. 4,4 × 109 / , - 22 / , 12,3 / .

 

?

 

*

 

+* 12

 

*

 

*


<== | ==>
4 | Ph -
:

: 2018-11-11; !; : 189 |

:

:

, .
==> ...

1715 - | 1468 -


© 2015-2024 lektsii.org - -

: 0.121 .